Literature DB >> 2478136

Lack of association of a restriction fragment length polymorphism for serum amyloid P gene with reactive amyloidosis.

N Harats1, B Kluve-Beckerman, M Skinner, M Passo, L Quinn, M D Benson.   

Abstract

The prevalence of a recently described restriction fragment length polymorphism using Msp I for the serum amyloid P gene was determined in 5 groups of patients. Patients with reactive (secondary) amyloidosis, juvenile rheumatoid arthritis, related inflammatory conditions, or juvenile rheumatoid arthritis with reactive amyloidosis, and healthy control subjects were found to be polymorphic for 8.8-kb and 5.6-kb gene fragments; they either had one or the other or both fragments. No significant differences were seen between these groups with relation to this polymorphism, and no correlation with the presence of reactive amyloidosis was observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478136     DOI: 10.1002/anr.1780321021

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  2 in total

1.  Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis.

Authors:  P N Hawkins; G A Tennent; P Woo; M B Pepys
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

2.  Amyloid resistance in A/J mice is not determined by genetic variants at, or close to, the serum amyloid P component locus.

Authors:  A S Whitehead; W Gonnerman; D M Steel; K Zahedi
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.